Sutro Biopharma (STRO) — Cash Flow Reinvestment Rate
Sutro Biopharma (STRO) has a Cash Flow Reinvestment Rate of 8.58x as of June 2024, reinvesting $81.13 Million (capex $756.00K plus investments $-80.38 Million) from operating cash flow of $9.46 Million. Explore STRO capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Sutro Biopharma Cash Flow Reinvestment Rate (2018–2022)
Historical reinvestment intensity for Sutro Biopharma across 2 annual periods. Also explore Sutro Biopharma asset portfolio for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Sutro Biopharma (2018–2022)
Year-by-year capital reinvestment analysis for Sutro Biopharma. For live market cap and broader valuation context, see market cap of Sutro Biopharma.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2022 | 12.08x | $42.88 Million | $3.55 Million | $7.86 Million | ▲ +90.9% |
| 2018 | 6.33x | $80.27 Million | $12.68 Million | $1.56 Million | — |